WHI SERIES STEERING COMMITTEE 2022
WHY ATTEND?
Reproductive health is set to hold a leading market share of the women’s health industry, with an estimated global worth of $171 billion by 2027.
Start-ups, Femtech, and Technology Innovators are driving the acceleration of new and improved solutions for the unmet needs of people’s reproductive health journeys.
The Reproductive Health Innovation Summit (January 25-26) is the destination for uncovering what is next in fertility, contraception and maternal health, from AI and big data to genetic testing, laboratory automation, consumer wearables, non-hormonal devices & solutions and new care delivery models.
Join us to:
- Tackle the challenges that straddle the reproductive health sector, including funding, insurance coverage, access and DTC business-models.
- Dive into 1 of our 3 leading innovation tracks: Contraception, Fertility or Maternal Health to discover the latest research, innovations and sector-specific challenges and opportunities.
- Network with the leaders and changemakers with numerous 1-2-1 opportunities, investor clinics and interactive roundtables throughout the 2 days.
Add to the innovation and attend alongside our leading network of biotechs, start-ups, Femtech, insurers, CROs, investors, medical device companies, researchers, pharmaceuticals, HCPs and advocacy groups to drive innovation at the convergence of healthcare and technology.
2021 Partners
2021 Headline Partner
Organon
Website: https://www.organon.com/
Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, N.J.
2021 Associate Partners
Health Decisions
Website: https://www.healthdec.com/
Health Decisions is a full-service CRO specializing in the clinical development of women’s health and diagnostics assets. Health Decisions has supported more than 200 clinical trials in women's health indications including contraception, menstrual disorders, menopausal symptoms and risk of preterm birth.
Sagentia Innovation
Website: www.sagentiainnovation.com
Sagentia Innovation provides independent advisory and leading-edge product development services focused on science and technology initiatives. Working across the medical, industrial, chemicals and energy, food and beverage, and consumer sectors, Sagentia Innovation works with a broad range of companies from some of the world’s leading and best-known brands, to start-up disruptors, new to the market. It is part of Science Group (AIM:SAG), which has more than ten offices globally, two UK-based dedicated R&D innovation centres and more than 400 employees. Other Science Group companies include Leatherhead Food Research, TSG Consulting and Frontier Smart Technologies.
ICON PLC
Website: https://iconplc.com/
ICON plc is a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON employs approximately 16,000 employees in 93 locations in 41 countries. Further information is available at www.iconplc.com.
Innovo
Website: www.myinnovo.com
Based in Galway, Ireland and Boston, MA, Atlantic Therapeutics develops consumer medical devices, related software, apps and connected health technologies to treat all types of incontinence, including INNOVO®, an FDA-Approved, CE-marked treatment for women suffering from Stress Urinary Incontinence. We believe that every woman deserves the freedom and confidence of good pelvic health and access to safe and effective treatments to achieve that outcome. Atlantic Therapeutics has attracted both international VC investment and enterprise grant funding and is now poised to begin this exciting new phase of growth and establish itself as the leading Femtech solution provider to treat SUI.
2021 Oncology Partners
GSK
Website: https://www.gsk.com/en-gb/
GSK is focused on maximising patient survival through transformational medicines. GSK’s pipeline is focused on immuno-oncology, cell therapy, cancer epigenetics and synthetic lethality. Our goal is to achieve a sustainable flow of new treatments based on a diversified portfolio of investigational medicines utilising modalities such as small molecules, antibodies, antibody drug conjugates and cells, either alone or in combination. We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. For further information please visit www.gsk.com/about-us
2021 KNOWLEDGE PARTNERS
McKinsey & Company
Website: https://www.mckinsey.com
McKinsey & Company is a global management consulting firm committed to helping organizations create Change that Matters.
In more than 130 cities and 65 countries, our teams help clients across the private, public and social sectors shape bold strategies and transform the way they work, embed technology where it unlocks value, and build capabilities to sustain the change. Not just any change, but Change that Matters – for their organizations, their people, and in turn society at large.
2021 Event Partners
Celanese
Website: https://bit.ly/3a0JriQ
Celanese works closely with you as a strategic partner to create innovative controlled-release dosage forms for biologics and small molecules to meet the goals of patient-centric therapies, improved medicine and better healthcare economics. Our VitalDose® EVA copolymer drug-delivery platform is an enabling technology for drug-eluting implants, inserts and transdermal films. The platform is flexible and customizable to address a variety of formulation challenges when it comes to tailoring the release rate of your drug.
- Compatible with biologics and small molecules
- Provides reliable local or systemic drug administration
- High drug loading capacity (≤ 75%)
- Engineered long-acting dosage profiles (zero-order or nonlinear profiles)
- Ease of formulation and configurable into a variety of geometries
- An established regulatory path with long clinical use history
From FEASIBILITY to DEVELOPMENT to COMMERCIALIZATION
Our scientists and engineers are there from concept to commercialization, providing development services, material supply aligned with GMP principles and regulatory support.
EMBR Labs
Website: https://embrlabs.com/?rfsn=3729439.9fc2d8f
Please visit our website for more information.Watkins-Conti Products Inc
Website: http://www.watkinscontiproducts.com/
Watkins Conti Products, Inc. is a Female founded and owned, Platform Women’s Healthcare company and product design firm that is focused on the creation of innovative and affordable consumer medical devices.
The company’s flagship product is a non-invasive solution for stress incontinence in women. The problem impacts and estimated ONE in THREE women globally. The disruptive, patented product offers multiple recurring revenue streams. Watkins-Conti has additional products in the pipeline to improve the consumer experience, specifically for health related issues that women face that are often seen as shameful or taboo.
Springboard Enterprises
Website: https://sb.co/
Springboard’s mission is to accelerate the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts. It is the leading network of influencers, investors and innovators dedicated to building high-growth companies led by women who are transforming industries in technology and life science.
Women's Health Innovation Coalition
Website: https://www.womens.health/
We are a coalition of organizations advocating and promoting greater attention, research, and investment in diseases, conditions, and indications that exclusively or predominantly impact women. Understanding that women are biologically different than their male counterparts, has led to the identification of gaps in women’s health outcomes. This has created new opportunities to fill these gaps through sourcing solutions from innovators. We have made it a priority to prove that women’s health is not a niche market and are driving initiative to promote greater gender-relevant data transparency to spur innovation and better health outcomes for all.
Become a Partner
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
AUDIENCE BREAKDOWN
2021 Speakers
John Berrios
David Sable
Barbara Collura
Sabrina Johnson
Kelly Ketterson
Lindsey Conon
Evan Sussman
Elizabeth Bailey
Eva Lathrop, MD, MPH
David Feigal
Dr. Jane van Dis, MD
Reenita Das
Kathryn G. Schubert, MPP
Temitayo Erogbogbo
Gregory S. Kopf, PhD
Download 2021 agenda
We're still finalising the agenda for the Reproductive Health Innovation Summit. In the meantime, please complete the form to access the 2021 Women's Health Innovation Summit (WHIS) Agenda to get an understanding of the format and the topics we'll be covering.
“This summit is a wonderful opportunity to learn about exciting innovations on the horizon and connect with potential collaborators in Women's Health.” Allison Conti, Watkins-Conti Products
Take a look at 2019 highlights:
Download the agenda for the Women's Health Innovation Summit 2021
Returning Safely Measures
Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.
All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.
Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.